-
2010
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
-
Meet us
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
2005
4 December 2005:
Stock Exchange Announcement no. 2: Zealand Pharma withdraws IPO24
24 November 2005:
Stock Exchange Announcement no. 1: Zealand Pharma publishes offering memorandum in connection with its listing on the Copenhagen Stock Exchange
11 November 2005:
Zealand Pharma appoints Business Development Officer
12 September 2005:
Zealand Pharma appoints new officer to lead drug development
29 August 2005:
Zealand Pharma completes second stage of its international €26 (USD34) million financing
25 April 2005:
Zealand Pharma appoints new Chief Financial Officer
4 March 2005:
Zealand Pharma enters into expanded collaboration agreement with Wyeth Pharmaceutical
3 March 2005:
Sanofi-Aventis finalize phase IIa clinical study with GLP-1 agonist for type 2 diabetes licensed from Zealand Pharma
21 February 2005:
Zealand Pharma completes first stage of its international €26 (USD34) million financing
10 January 2005:
Zealand Pharma raises € 13,3 million (USD 18 million) in new financing
Home Legal Disclaimer Updated: 27.7.2010